Patents for Chemicals, Pharmaceuticals, and Biotechnology: Fundamentals of Global Law, Practice, and Strategy

By Philip W. Grubb | Go to book overview

INDEX
abandonment 6, 79-80
abstract 95-6, 113, 134, 329-30
adrenalin 213
agreements, seecontracts
ambiguity:
of claims 178
of contracts 407
amendment:
after grant (EPO) 186; ( UK) 180-1; ( USA) 183-4
damages after amendment 167
during prosecution (EPO) 120; (PCT) 133, 136, 316; ( UK) 96-7, 100; ( USA) 104, 106
in opposition proceedings (EPO) 123, 190
to the EPC 255
to the TRIPs agreement 46
amoxicillin 200
ampicillin 211
Andean Pact Countries 36
antibiotics 213, 225, 231
antibodies 239
monoclonal 240-2, 311
anticipation 57, 180, 210, 305, 319-20 See alsonovelty
accidental 320
anti-sense 242
anti-trust 413, 426-8
appeal (EPO) 123, 126-9, 189-90; ( Germany) 170-1; ( Japan) 174; ( UK) 100, 163; (USA) 105, 157; (WTO) 39
application for patent see alsofiling:
continuation 106-7, 140, 376
continuation-in-part 26, 106, 140, 321, 350
continued prosecution application 106
convention 25
divisional 89, 107, 117, 121-2, 313-7, 326
European 57, 76, 82-4, 93, 112-3, 120, 332, 339, 348, 351, 361, 363
International (PCT) 29, 85, 130, 132, 135, 315-6, 332, 336, 338, 341
priority 25, 71, 76-8, 80, 238, 404
application, industrial 53, 61, 63, 177, 210-11, 254, 257
Argentina26, 39-40, 43, 145, 299
assignment 168, 352-3, 363, 422, 430
Australia93, 150, 163, 307, 332
Austria117, 122, 145, 358
Belgium86, 88, 93
best mode requirement ( UK) 178; ( USA) 77, 183-4, 296-7
biotechnology industry 187, 207, 219, 370-3, 402
Biotechnology Patenting Directive (BPD) 253-6
black box application 33, 41-3
black clauses 423-4
block exemption:
patents 421-3
technology transfer 423-4, 431
Bolar:
Roche v. Bolar147, 162
"Bolar exemptions"162-3, 368
Brazil36-7, 40, 42, 87, 145
British Technology Group ( BTG) 355, 374
Budapest Treaty 228, 300
Canada6, 65, 67, 92, 140, 163
cell therapy 242-3
certificate:
of correction 185
of grant 4, 100, 117
of invention 36, 38
of validity 168
Certificate in Intellectual Property Law 275-6
Certificate of Complementary Protection (CCP) 142
Chartered Institute of Patent Agents 18, 274
Chartered Patent Agent 274
in industrial practice 282-3
in private practice 281-2
Chemical Abstracts336-7, 339
China44
claims 18, 303-11
dependent 203, 305, 379
fingerprint 202, 226
free beer 311
interpretation of 214, 236, 303, 379-85
omnibus 309
product-by-process 304
classification 335-6
clauses (in licence agreement)
no-challenge 422, 429-30
severability 410, 425
tie-in 161, 413, 422, 426, 428-9
Clayton Act 426
clean hands doctrine 170, 426
combinatorial chemistry 214-5, 261
comfort letter 431
common law 8-9, 18-19, 256, 351-2
comparison with prior art 104, 183, 296, 322-5

-443-

Notes for this page

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this book

This book has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this book

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this page

Cited page

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited page

Bookmark this page
Patents for Chemicals, Pharmaceuticals, and Biotechnology: Fundamentals of Global Law, Practice, and Strategy
Table of contents

Table of contents

Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this book

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen
/ 448

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.